Colinz Laboratories Ltd

BSE: 531210
Colinz Laboratories Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24200MH1986PLC041128 Incorporated 06 October 1986 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 531210 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹6.14 Cr
▼ 6% YoY
Computed EBITDA · FY 2026
₹89.2 Lakh
▲ 12.48% YoY
Net profit · FY 2026
₹51.45 Lakh
▲ 3.6% YoY
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹2.52 Cr
Issued & subscribed
Open charges
None
Satisfied ₹1.98 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
29
Latest available

About Colinz Laboratories Ltd

Data last updated: 14 July 2026

Colinz Laboratories Ltd is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 06 October 1986, the company has been in operation for over 40 years.

Registered with ROC Mumbai under CIN L24200MH1986PLC041128. Listed on BSE: 531210.

Capital: an authorised share capital of ₹6 Cr and a paid-up capital of ₹2.52 Cr. Formerly known as Colinz Laboratories Private Limited. It is led by directors including Narayanan Kutty Menon and Vijaya Mani.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A 101 Pratik Ind Estatemulund Goregaon Link Road Bhandup West, Mumbai, Maharashtra, India – 400078.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹6.14 Cr, a decline of 6% compared to the previous year. The net worth stands at ₹10.04 Cr (up 6% YoY). Total assets are valued at ₹12.78 Cr (up 8.16% YoY).

The company has a workforce of approximately 29 employees as per the latest available data.

The company is associated with 1 brand - Colinz Laboratories. As per MCA filings, the company has satisfied charges of ₹1.98 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website colinz.com.

Company Details of Colinz Laboratories Ltd
CIN L24200MH1986PLC041128
Registration Number 041128
Incorporation Date 06 October 1986
ROC Mumbai
Listing Status Listed (BSE: 531210)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Narayanan Kutty Menon Whole-Time Director Vijaya Mani Additional Director Baptist Bernard Dias Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    colinz.com
  • Social Media
  • Registered Address
    A 101 Pratik Ind Estatemulund Goregaon Link Road Bhandup West, Mumbai, Maharashtra, India – 400078
  • Industry
    Pharma, Drug Formulation & Development
Company report
Colinz Laboratories Ltd - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Colinz Laboratories Ltd report

Financials, compliance, directors, charges, ownership and filings for Colinz Laboratories Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Colinz Laboratories Ltd

Colinz Laboratories Ltd operates one associated brand: Colinz Laboratories. These brands represent Colinz Laboratories Ltd's diversified market presence and brand portfolio.

Brand Description Website
Colinz Laboratories
Pharmaceutical formulations in allopathic, ayurvedic, and nutraceutical forms are manufactured. colinz.com

Business Activity of Colinz Laboratories Ltd

Colinz Laboratories Ltd is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Colinz Laboratories Ltd

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Colinz Laboratories Ltd

Colinz Laboratories Ltd is audited by VORA AND ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-09-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
VORA AND ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-09-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Colinz Laboratories Ltd

Colinz Laboratories Ltd is currently managed by 4 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Narayanan Kutty Menon
Also directs: Alvaro Healthcare Private Limited
Whole-Time Director 01 Oct 2004 21 Years 10 Months Current
Vijaya Mani
Also directs: Bueno Healthcare Private Limited
Additional Director 11 Nov 2025 0 Years 9 Months Current
Baptist Bernard Dias Director 08 Aug 2024 2 Years 0 Months Current
Bhavik Ashokkumar Shah
Also directs: Omnitex Industries (India) Limited, Gaekwar Mills Limited, Msl Global Limited and 2 more
Director 08 Aug 2024 2 Years 0 Months Current
View all directors

Financials of Colinz Laboratories Ltd FY 2026 filings available

Colinz Laboratories Ltd reported revenue of ₹6.14 Cr (down 6% YoY) for FY 2026.

Revenue · FY 2026
₹6.14 Cr ▼ 6%
Profit · FY 2026
₹51.45 Lakh ▲ 3.6%
Computed EBITDA · FY 2026
₹89.2 Lakh ▲ 12.48%
Revenue₹ Cr · Standalone0510FY 2019: ₹8 Cr7.7FY 2019FY 2020: ₹8 Cr · -0.8% YoY7.6-0.8%FY 2020FY 2021: ₹6 Cr · -19% YoY6.2-19%FY 2021FY 2022: ₹7 Cr · +13.2% YoY7+13.2%FY 2022FY 2023: ₹7 Cr · +2.6% YoY7.2+2.6%FY 2023FY 2024: ₹7 Cr · -1.8% YoY7-1.8%FY 2024FY 2025: ₹7 Cr · -7.1% YoY6.5-7.1%FY 2025FY 2026: ₹6 Cr · -6% YoY6.1-6%FY 2026
Net Profit₹ Cr · Standalone00.20.40.6FY 2019: ₹0 Cr0.1FY 2019FY 2020: ₹0 Cr · +7.1% YoY0.1+7.1%FY 2020FY 2021: ₹0 Cr · +59.2% YoY0.2+59.2%FY 2021FY 2022: ₹0 Cr · +63.4% YoY0.3+63.4%FY 2022FY 2023: ₹0 Cr · +34.8% YoY0.5+34.8%FY 2023FY 2024: ₹0 Cr · +6.4% YoY0.5+6.4%FY 2024FY 2025: ₹0 Cr · +2% YoY0.5+2%FY 2025FY 2026: ₹1 Cr · +3.6% YoY0.5+3.6%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year012Q1'25: ₹2 Cr1.7Q1'25Q2'25: ₹2 Cr1.9Q2'25Q3'25: ₹1 Cr1.5Q3'25Q4'25: ₹1 Cr1.5Q4'25Q1'26: ₹2 Cr · -10.3% YoY1.6-10.3%Q1'26Q2'26: ₹1 Cr · -25.5% YoY1.4-25.5%Q2'26Q3'26: ₹1 Cr · -2.2% YoY1.4-2.2%Q3'26Q4'26: ₹2 Cr · +20.4% YoY1.7+20.4%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹6.14 Cr ₹6.53 Cr ₹7.03 Cr ₹7.15 Cr ₹6.97 Cr ₹6.16 Cr ₹7.6 Cr ₹7.67 Cr
Other Income ₹48.44 Lakh ₹29.79 Lakh ₹27.5 Lakh ₹17.21 Lakh ₹17.08 Lakh ₹19.1 Lakh ₹13.49 Lakh ₹11.84 Lakh
Total Income ₹6.62 Cr ₹6.83 Cr ₹7.3 Cr ₹7.33 Cr ₹7.15 Cr ₹6.35 Cr ₹7.74 Cr ₹7.79 Cr
Cost of Materials Consumed ₹57.05 Lakh ₹55.54 Lakh ₹50.87 Lakh ₹61.78 Lakh ₹60.13 Lakh ₹54.73 Lakh ₹81.56 Lakh ₹93.34 Lakh
Purchases of Stock-in-Trade ₹1.12 Cr ₹1.45 Cr ₹1.72 Cr ₹1.71 Cr ₹1.37 Cr ₹1.17 Cr ₹1.81 Cr ₹1.79 Cr
Changes in Inventories ₹1.5 Lakh ₹8.19 Lakh ₹8.11 Lakh -₹3.32 Lakh ₹32.8 Lakh ₹46.87 Lakh ₹12.02 Lakh ₹7.69 Lakh
Employee Benefit Expense ₹2.7 Cr ₹2.84 Cr ₹2.95 Cr ₹3.03 Cr ₹2.9 Cr ₹2.51 Cr ₹3.52 Cr ₹3.37 Cr
Finance Costs ₹4.66 Lakh ₹4.24 Lakh ₹3.72 Lakh ₹5.23 Lakh ₹7.55 Lakh ₹8.65 Lakh ₹6.68 Lakh ₹9.74 Lakh
Depreciation & Amortisation ₹15.63 Lakh ₹13.12 Lakh ₹13.03 Lakh ₹12.89 Lakh ₹20.11 Lakh ₹19.13 Lakh ₹19.48 Lakh ₹21.59 Lakh
Other Expenses ₹1.32 Cr ₹1.1 Cr ₹1.22 Cr ₹1.22 Cr ₹1.19 Cr ₹1.13 Cr ₹1.04 Cr ₹1.15 Cr
Total Expenses ₹5.93 Cr ₹6.21 Cr ₹6.65 Cr ₹6.73 Cr ₹6.66 Cr ₹6.1 Cr ₹7.56 Cr ₹7.63 Cr
Profit Before Exceptional Items & Tax ₹68.91 Lakh ₹61.94 Lakh ₹65.03 Lakh ₹59.98 Lakh ₹48.03 Lakh ₹24.52 Lakh ₹17.6 Lakh ₹15.57 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹68.91 Lakh ₹61.94 Lakh ₹65.03 Lakh ₹59.98 Lakh ₹48.03 Lakh ₹24.52 Lakh ₹17.6 Lakh ₹15.57 Lakh
Total Tax Expense ₹17.46 Lakh ₹12.28 Lakh ₹16.36 Lakh ₹14.24 Lakh ₹14.1 Lakh ₹3.76 Lakh ₹4.56 Lakh ₹3.83 Lakh
Net Profit ₹51.45 Lakh ₹49.66 Lakh ₹48.67 Lakh ₹45.74 Lakh ₹33.93 Lakh ₹20.76 Lakh ₹13.04 Lakh ₹12.17 Lakh
Other Comprehensive Income ₹5.42 Lakh ₹2.89 Lakh ₹32.3 Lakh -₹57,000 ₹5.68 Lakh ₹24.46 Lakh -₹13.53 Lakh -₹3.01 Lakh
Total Comprehensive Income ₹56.87 Lakh ₹52.55 Lakh ₹80.97 Lakh ₹45.17 Lakh ₹39.61 Lakh ₹45.22 Lakh -₹49,000 ₹9.16 Lakh
EBITDA (computed) ₹89.2 Lakh ₹79.3 Lakh ₹81.78 Lakh ₹78.1 Lakh ₹75.69 Lakh ₹52.3 Lakh ₹43.76 Lakh ₹46.9 Lakh
Basic EPS ₹2.04 ₹1.97 ₹1.93 ₹1.82 ₹0.74 ₹0.99 ₹0.00 ₹0.20
Diluted EPS ₹2.04 ₹1.97 ₹1.93 ₹1.82 ₹0.74 ₹0.99 ₹0.00 ₹0.20
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹12.78 Cr ₹11.82 Cr ₹11.36 Cr ₹10.23 Cr ₹9.93 Cr ₹10.09 Cr ₹8.81 Cr ₹9.17 Cr
Non-current Assets ₹2.7 Cr ₹2.8 Cr ₹2.62 Cr ₹2.4 Cr ₹2.55 Cr ₹2.83 Cr ₹2.97 Cr ₹3.53 Cr
Current Assets ₹10.08 Cr ₹9.02 Cr ₹8.74 Cr ₹7.84 Cr ₹7.38 Cr ₹7.26 Cr ₹5.84 Cr ₹5.64 Cr
Property, Plant & Equipment ₹1.54 Cr ₹1.7 Cr ₹1.58 Cr ₹1.71 Cr ₹1.86 Cr ₹2.03 Cr ₹2.06 Cr ₹2.21 Cr
Inventories ₹70.35 Lakh ₹78.09 Lakh ₹84.69 Lakh ₹93.88 Lakh ₹92.52 Lakh ₹1.25 Cr ₹1.69 Cr ₹1.9 Cr
Trade Receivables ₹83.51 Lakh ₹66.09 Lakh ₹85.92 Lakh ₹1.13 Cr ₹1.21 Cr ₹1.3 Cr ₹1.49 Cr ₹1.68 Cr
Cash & Equivalents ₹70.34 Lakh ₹2.4 Cr ₹2.95 Cr ₹1.97 Cr ₹2.09 Cr ₹1.39 Cr ₹41.4 Lakh ₹27.51 Lakh
Equity (Net Worth) ₹10.04 Cr ₹9.47 Cr ₹8.95 Cr ₹8.14 Cr ₹7.69 Cr ₹7.29 Cr ₹6.84 Cr ₹6.84 Cr
Equity Share Capital ₹2.52 Cr ₹2.52 Cr ₹2.52 Cr ₹2.52 Cr ₹3.55 Cr ₹3.55 Cr ₹3.54 Cr ₹3.54 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹38.99 Lakh ₹64.09 Lakh ₹56.98 Lakh ₹27.34 Lakh ₹48.45 Lakh ₹99.26 Lakh ₹38.06 Lakh ₹67.54 Lakh
Total Debt (computed) ₹38.99 Lakh ₹64.09 Lakh ₹56.98 Lakh ₹27.34 Lakh ₹48.45 Lakh ₹99.26 Lakh ₹38.06 Lakh ₹67.54 Lakh
Current Liabilities ₹2.74 Cr ₹2.16 Cr ₹2.18 Cr ₹1.89 Cr ₹1.98 Cr ₹2.57 Cr ₹1.61 Cr ₹1.79 Cr
Total Liabilities ₹2.74 Cr ₹2.34 Cr ₹2.41 Cr ₹2.09 Cr ₹2.24 Cr ₹2.8 Cr ₹1.97 Cr ₹2.33 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹2.54 Cr -₹1.45 Cr ₹1.03 Cr ₹40.27 Lakh ₹46.72 Lakh
Investing Cash Flow ₹48.45 Lakh ₹4.6 Lakh ₹27.37 Lakh ₹17.21 Lakh ₹13.33 Lakh
Financing Cash Flow -₹4.66 Lakh -₹4.24 Lakh -₹3.72 Lakh -₹5.23 Lakh -₹7.55 Lakh
Capital Expenditure ₹0 ₹26.19 Lakh ₹0 ₹0 ₹3.75 Lakh
Free Cash Flow (computed) ₹2.54 Cr -₹1.72 Cr ₹1.03 Cr ₹40.27 Lakh ₹42.97 Lakh
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹2.98 Cr -₹1.45 Cr ₹1.27 Cr ₹52.25 Lakh ₹52.5 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹1.75 Cr ₹1.43 Cr ₹1.39 Cr ₹1.57 Cr ₹1.45 Cr ₹1.47 Cr ₹1.86 Cr ₹1.75 Cr
Other Income ₹17.45 Lakh ₹7.54 Lakh ₹15.93 Lakh ₹7.52 Lakh ₹7.56 Lakh ₹7.74 Lakh ₹7.77 Lakh ₹6.73 Lakh
Total Income ₹1.92 Cr ₹1.51 Cr ₹1.55 Cr ₹1.64 Cr ₹1.53 Cr ₹1.54 Cr ₹1.94 Cr ₹1.81 Cr
Cost of Materials Consumed ₹11.37 Lakh ₹10.69 Lakh ₹16.26 Lakh ₹18.73 Lakh ₹9.58 Lakh ₹16.53 Lakh ₹14.14 Lakh ₹15.29 Lakh
Purchases of Stock-in-Trade ₹25.73 Lakh ₹26.18 Lakh ₹17.89 Lakh ₹42.68 Lakh ₹26.91 Lakh ₹41.04 Lakh ₹42.36 Lakh ₹34.98 Lakh
Changes in Inventories ₹21.14 Lakh ₹10.32 Lakh -₹8.52 Lakh -₹21.44 Lakh ₹14.09 Lakh -₹10.59 Lakh -₹92,000 ₹5.61 Lakh
Employee Benefit Expense ₹69.5 Lakh ₹58.42 Lakh ₹75.92 Lakh ₹65.71 Lakh ₹69.72 Lakh ₹68.7 Lakh ₹73.42 Lakh ₹72.1 Lakh
Finance Costs ₹1.05 Lakh ₹1.13 Lakh ₹1.31 Lakh ₹1.16 Lakh ₹1.61 Lakh ₹54,000 ₹1.16 Lakh ₹93,000
Depreciation & Amortisation ₹3.91 Lakh ₹3.91 Lakh ₹3.91 Lakh ₹3.91 Lakh ₹3.46 Lakh ₹3.22 Lakh ₹3.22 Lakh ₹3.22 Lakh
Other Expenses ₹37.96 Lakh ₹27.69 Lakh ₹29.31 Lakh ₹37.31 Lakh ₹15.01 Lakh ₹24.62 Lakh ₹39.88 Lakh ₹30.79 Lakh
Total Expenses ₹1.71 Cr ₹1.38 Cr ₹1.36 Cr ₹1.48 Cr ₹1.4 Cr ₹1.44 Cr ₹1.73 Cr ₹1.63 Cr
Profit Before Exceptional Items & Tax ₹21.58 Lakh ₹12.61 Lakh ₹18.65 Lakh ₹16.07 Lakh ₹12.32 Lakh ₹10.33 Lakh ₹20.82 Lakh ₹18.47 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹21.58 Lakh ₹12.61 Lakh ₹18.65 Lakh ₹16.07 Lakh ₹12.32 Lakh ₹10.33 Lakh ₹20.82 Lakh ₹18.47 Lakh
Total Tax Expense ₹4.46 Lakh ₹4.25 Lakh ₹4.6 Lakh ₹4.15 Lakh -₹2.72 Lakh ₹5 Lakh ₹5.25 Lakh ₹4.75 Lakh
Net Profit ₹17.12 Lakh ₹8.36 Lakh ₹14.05 Lakh ₹11.92 Lakh ₹15.04 Lakh ₹5.33 Lakh ₹15.57 Lakh ₹13.72 Lakh
Other Comprehensive Income -₹16.79 Lakh ₹7.93 Lakh ₹5.15 Lakh ₹9.13 Lakh ₹4.53 Lakh -₹12.11 Lakh ₹2.28 Lakh ₹8.2 Lakh
Total Comprehensive Income ₹33,000 ₹16.29 Lakh ₹19.2 Lakh ₹21.05 Lakh ₹19.57 Lakh -₹6.78 Lakh ₹17.85 Lakh ₹21.92 Lakh
EBITDA (computed) ₹26.54 Lakh ₹17.65 Lakh ₹23.87 Lakh ₹21.14 Lakh ₹17.39 Lakh ₹14.09 Lakh ₹25.2 Lakh ₹22.62 Lakh
Basic EPS ₹0.68 ₹0.33 ₹0.56 ₹0.54 ₹0.60 ₹0.00 ₹0.62 ₹0.54
Diluted EPS ₹0.68 ₹0.33 ₹0.56 ₹0.54 ₹0.60 ₹0.00 ₹0.62 ₹0.54
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Colinz Laboratories Ltd. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Colinz Laboratories Ltd

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 66.00%, retail and other public shareholders hold 34.00% of Colinz Laboratories Ltd. The company had 3,250 shareholders on record.

Promoters: 66.00%Retail & Others: 34.00%
Mar 2026
QUARTER
66.00% Promoters
34.00% Retail & Others
Promoter holding - history
Now 66.00% · Mar 2026High 66.00% · Jun 2023Low 65.92% · Sep 2024
64%64.8%65.5%66.3%67%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 66.00%Sep 2023: 66.00%Dec 2023: 66.00%Mar 2024: 66.00%Jun 2024: 66.00%Sep 2024: 65.92%Dec 2024: 66.00%Mar 2025: 66.00%Jun 2025: 66.00%Sep 2025: 66.00%Dec 2025: 66.00%Mar 2026: 66.00%66.00%65.92%66.00%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters66.00%66.00%66.00%66.00%66.00%66.00%
Public34.00%34.00%34.00%34.00%34.00%34.00%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters66.00%66.00%66.00%
Public34.00%34.00%34.00%
Promoter change (YoY, %pts)+0.00+0.00-

Charges & Borrowings of Colinz Laboratories Ltd

Open charges
₹0
Satisfied charges
₹1.98 Cr
Breakdown by lending institutions
Bank of Baroda₹1.98 Cr
Latest charge details
DateLenderAmountStatus
01 Mar 1999 Bank of Baroda ₹1.15 Cr Satisfied
15 Oct 1998 Bank of Baroda ₹13.22 Lakh Satisfied
25 Aug 1994 Bank of Baroda ₹39 Lakh Satisfied
15 Jan 1993 Bank of Baroda ₹19.8 Lakh Satisfied
19 Aug 1987 Bank of Baroda ₹11.4 Lakh Satisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Colinz Laboratories Ltd

Colinz Laboratories Ltd has a workforce of 29 employees as of Mar 23, 2024.

Employee count
29
Active EPFO establishments
1
Employee growth
7.41%
Premium access

Employee and EPFO history for Colinz Laboratories Ltd

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Colinz Laboratories Ltd

Premium access

GST registrations and filing compliance for Colinz Laboratories Ltd

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Colinz Laboratories Ltd

Premium access

Credit ratings, litigation, and regulatory alerts for Colinz Laboratories Ltd

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Colinz Laboratories Ltd

Premium access

MSME payment history for Colinz Laboratories Ltd

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Colinz Laboratories Ltd

Premium access

Corporate group structure for Colinz Laboratories Ltd

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Colinz Laboratories Ltd

Premium access

MCA filings and documents for Colinz Laboratories Ltd

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Colinz Laboratories Ltd

Directors
18 Dec 2025
Falguni Kumawat was appointed as a Company Secretary on 18 Dec 2025 & has been associated with this company since 8 months 1 day.
Directors
11 Nov 2025
Vijaya Mani was appointed as a Additional Director on 11 Nov 2025 & has been associated with this company since 9 months 8 days.
Activity
30 Sep 2025
Colinz Laboratories Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Colinz Laboratories Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
08 Aug 2024
Baptist Bernard Dias was appointed as a Director on 08 Aug 2024 & has been associated with this company since 2 years 11 days.
Directors
08 Aug 2024
Bhavik Ashokkumar Shah was appointed as a Director on 08 Aug 2024 & has been associated with this company since 2 years 11 days.

Recent News on Colinz Laboratories Ltd

Frequently Asked Questions about Colinz Laboratories Ltd

Colinz Laboratories Ltd is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 06 October 1986 (40+ years old) and is registered under CIN L24200MH1986PLC041128. Listed on BSE: 531210. The company has 29 employees.

Colinz Laboratories Ltd reported revenue of ₹6.14 Cr for FY 2026 (down 6% YoY) based on standalone BSE filings.

The current directors of Colinz Laboratories Ltd are:

The primary industry of Colinz Laboratories Ltd is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Colinz Laboratories Ltd is listed on BSE with code 531210.

Colinz Laboratories Ltd can be reached at the registered office: A 101 Pratik Ind Estatemulund Goregaon Link Road Bhandup West, Mumbai, Maharashtra, India – 400078, or through the website colinz.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available